Stephanie Shiau1, Stephen M Arpadi2,3,4, Yanhan Shen2, Anyelina Cantos5, Christian Vivar Ramon5, Jayesh Shah5, Grace Jang5, Jennifer J Manly2,6,7, Adam M Brickman2,6,7, Andrea A Baccarelli8, Michael T Yin5. 1. Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey, USA. 2. Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA. 3. Department of Pediatrics, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA. 4. ICAP at Columbia, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York, USA. 5. Department of Medicine, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA. 6. Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York, USA. 7. Department of Neurology, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA. 8. Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York, USA.
Abstract
BACKGROUND: Accelerated epigenetic aging using DNA methylation (DNAm)-based biomarkers has been reported in people with human immunodeficiency virus (HIV, PWH), but limited data are available among African Americans (AA), women, and older PWH. METHODS: DNAm was measured using Illumina EPIC Arrays for 107 (69 PWH and 38 HIV-seronegative controls) AA adults ≥60 years in New York City. Six DNAm-based biomarkers of aging were estimated: (1) epigenetic age acceleration (EAA), (2) extrinsic epigenetic age acceleration (EEAA), (3) intrinsic epigenetic age acceleration (IEAA), (4) GrimAge, (5) PhenoAge, and (6) DNAm-estimated telomere length (DNAm-TL). The National Institutes of Health (NIH) Toolbox Cognition Battery (domains: executive function, attention, working memory, processing speed, and language) and Montreal Cognitive Assessment (MoCA) were administered. Participants were assessed for frailty by the Fried criteria. RESULTS: The PWH and control groups did not differ by sex, chronological age, or ethnicity. In total, 83% of PWH had a viral load <50 copies/mL, and 94% had a recent CD4 ≥200 cells/µL. The PWH group had a higher EAA, EEAA, GrimAge, and PhenoAge, and a lower DNAm-TL compared to the controls. IEAA was not different between groups. For PWH, there were significant negative correlations between IEAA and executive function, attention, and working memory and PhenoAge and attention. No associations between biomarkers and frailty were detected. CONCLUSIONS: Evidence of epigenetic age acceleration was observed in AA older PWH using DNAm-based biomarkers of aging. There was no evidence of age acceleration independent of cell type National Institutes of Health composition (IEAA) associated with HIV, but this measure was associated with decreased cognitive function among PWH.
BACKGROUND: Accelerated epigenetic aging using DNA methylation (DNAm)-based biomarkers has been reported in people with human immunodeficiency virus (HIV, PWH), but limited data are available among African Americans (AA), women, and older PWH. METHODS: DNAm was measured using Illumina EPIC Arrays for 107 (69 PWH and 38 HIV-seronegative controls) AA adults ≥60 years in New York City. Six DNAm-based biomarkers of aging were estimated: (1) epigenetic age acceleration (EAA), (2) extrinsic epigenetic age acceleration (EEAA), (3) intrinsic epigenetic age acceleration (IEAA), (4) GrimAge, (5) PhenoAge, and (6) DNAm-estimated telomere length (DNAm-TL). The National Institutes of Health (NIH) Toolbox Cognition Battery (domains: executive function, attention, working memory, processing speed, and language) and Montreal Cognitive Assessment (MoCA) were administered. Participants were assessed for frailty by the Fried criteria. RESULTS: The PWH and control groups did not differ by sex, chronological age, or ethnicity. In total, 83% of PWH had a viral load <50 copies/mL, and 94% had a recent CD4 ≥200 cells/µL. The PWH group had a higher EAA, EEAA, GrimAge, and PhenoAge, and a lower DNAm-TL compared to the controls. IEAA was not different between groups. For PWH, there were significant negative correlations between IEAA and executive function, attention, and working memory and PhenoAge and attention. No associations between biomarkers and frailty were detected. CONCLUSIONS: Evidence of epigenetic age acceleration was observed in AA older PWH using DNAm-based biomarkers of aging. There was no evidence of age acceleration independent of cell type National Institutes of Health composition (IEAA) associated with HIV, but this measure was associated with decreased cognitive function among PWH.
Authors: Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow Journal: J Am Geriatr Soc Date: 2005-04 Impact factor: 5.562
Authors: Andrew M Gross; Philipp A Jaeger; Jason F Kreisberg; Katherine Licon; Kristen L Jepsen; Mahdieh Khosroheidari; Brenda M Morsey; Susan Swindells; Hui Shen; Cherie T Ng; Ken Flagg; Daniel Chen; Kang Zhang; Howard S Fox; Trey Ideker Journal: Mol Cell Date: 2016-04-21 Impact factor: 17.970
Authors: Richard C Gershon; Molly V Wagster; Hugh C Hendrie; Nathan A Fox; Karon F Cook; Cindy J Nowinski Journal: Neurology Date: 2013-03-12 Impact factor: 9.910
Authors: Salman M Tajuddin; Dena G Hernandez; Brian H Chen; Nicole Noren Hooten; Nicolle A Mode; Mike A Nalls; Andrew B Singleton; Ngozi Ejiogu; Kumaraswamy Naidu Chitrala; Alan B Zonderman; Michele K Evans Journal: Clin Epigenetics Date: 2019-08-19 Impact factor: 6.551
Authors: Chen Xi Yang; Emma Schon; Ma'en Obeidat; Michael S Kobor; Lisa McEwen; Julie MacIsaac; David Lin; Richard M Novak; Fleur Hudson; Hartwig Klinker; Nila Dharan; Steve Horvath; Jean Bourbeau; Wan Tan; Don D Sin; S F Paul Man; Ken Kunisaki; Janice M Leung Journal: J Infect Dis Date: 2021-05-28 Impact factor: 5.226
Authors: Carola Ingrid Weidner; Qiong Lin; Carmen Maike Koch; Lewin Eisele; Fabian Beier; Patrick Ziegler; Dirk Olaf Bauerschlag; Karl-Heinz Jöckel; Raimund Erbel; Thomas Walter Mühleisen; Martin Zenke; Tim Henrik Brümmendorf; Wolfgang Wagner Journal: Genome Biol Date: 2014-02-03 Impact factor: 13.583
Authors: Steve Horvath; Michael Gurven; Morgan E Levine; Benjamin C Trumble; Hillard Kaplan; Hooman Allayee; Beate R Ritz; Brian Chen; Ake T Lu; Tammy M Rickabaugh; Beth D Jamieson; Dianjianyi Sun; Shengxu Li; Wei Chen; Lluis Quintana-Murci; Maud Fagny; Michael S Kobor; Philip S Tsao; Alexander P Reiner; Kerstin L Edlefsen; Devin Absher; Themistocles L Assimes Journal: Genome Biol Date: 2016-08-11 Impact factor: 13.583
Authors: Abigail Baim-Lance; Matthew Angulo; Mary Ann Chiasson; Helen-Maria Lekas; Rachel Schenkel; Jason Villarreal; Anyelina Cantos; Christine Kerr; Aarthi Nagaraja; Michael T Yin; Peter Gordon Journal: BMC Health Serv Res Date: 2022-05-06 Impact factor: 2.908